Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Data Study Assessing the Efficacy of Troriluzole-Treated Subjects With Spinocerebellar Ataxia (SCA) Compared to a Matched External SCA Control Using Natural History Cohort Data

NCT06529146 is registered in ClinicalTrials.gov with Biohaven Therapeutics Ltd. as lead sponsor.

NCT NCT06529146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06529146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Data Study Assessing the Efficacy of Troriluzole-Treated Subjects With Spinocerebellar Ataxia (SCA) Compared to a Matched External SCA Control Using Natural History Cohort Data
Lead sponsor
Biohaven Therapeutics Ltd.
Phase
Observational
Overall status
Active, not recruiting
Start date
March 18, 2019
Completion date
August 31, 2026
Enrollment
909 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinocerebellar ataxias